DEA Denies to Reschedule Cannabis Again

Reschedule Cannabis
The entire Cannabis community has been collectively fighting to get the U.S. Drug Enforcement Administration (DEA) to finally announce drug reform by downgrading the Schedule I Classification of Marijuana. After the Medical Marijuana breakthrough votes in many states so far and the multitude of states currently voting on recreational cannabis, voters have been looking positive movement from the DEA. Reports were swirling around starting Wednesday about an announcement the DEA was going to be making on regarding marijuana and citizens seem to be hopeful that the DEA would finally take a step forward and reschedule cannabis to Schedule 2. The Announcement  failed to prove us with the fabled rescheduling and opened up the door for more Universities to open up to cultivate research with cannabis beyond the University of Mississippi. The DEA has stood firm on the decision that Cannabis has no medical value in their eyes mainly due to the U.S. Food and Drug Administration’s (FDA) opinion on the subject. Since the FDA says Cannabis currently has “No accepted Medical use in treatment in the United States” lawmakers are going to be unable to reschedule cannabis without further extensive research on the subject. 
Chuck Rosenburg acting administrator of the DEA wants the Cannabis Community to know that the decision to continue labeling marijuana among the most harmful substances has nothing to do with the Danger associated with it. With the understanding that cannabis has not been contributed to the death of a single person, the Administration says their decision based on , “This decision isn’t based on danger,” he told NPR. “This decision is based on whether marijuana, as determined by the FDA, is a safe and effective medicine… and it’s not.” The DEA is moving forward with an official announcement that will expand the amount of federally regulated locations cannabis can be grown for research purposes. In a letter sent out to Lawmakers petitioning the FDA to reschedule cannabis they outlined that in order to make a change in classification, “Evaluating the safety and effectiveness of drugs is a highly specialized endeavor,” and that the opinions of doctors all across the nation carried no weight in the decision to continue classifying marijuana a Schedule I drug under the Controlled Substances Act. Opening up more universities for legally controlled research is the first step of many on the way to officially having the FDA recognize Marijuana as a safe and effective medicine. 
It’s not currently know how many new research opportunities will be handed out to eager researchers around the scientific community. Many researchers have been vocal about the current research monopoly current held by the University of Mississippi and the stranglehold it has put on accomplishing any real work. Any opening to help speed up the investigation into life-changing cures by top Universities is looking like it’s going to be the only way to finally get the FDA to have a change of heart about marijuana. It’s sad that even after all of the leaps the cannabis industry has made, “Reefer Madness” still has a stranglehold on the Governements perception of Cannabis and is going to have to wait for that respect it’s due.

Leave a Comment